MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$8,347,090
Prepaid expenses and
other current assets
$920,038
Total current assets
$9,267,128
Operating lease
right-of-use asset
$1,483,156
Property, plant &
equipment, net
$339,697
Other long-term
assets
$29,780
Total assets
$11,119,761
Total liabilities and
stockholders' equity
$11,119,761
Total liabilities
$6,402,651
Total stockholders'
equity (deficit)
$3,335,087
Series d preferred
stock, 111.11 shares...
$1,382,023
Accumulated deficit
-$274,787,446
Total current
liabilities
$4,873,826
Lease liability, net
of current portion
$1,528,825
Additional paid-in capital
$277,601,713
Series e-2 preferred
stock, 1,225.00 shares...
$520,778
Common stock, 0.00001
par value...
$42
Accounts payable and
accrued liabilities
$4,724,826
Warrant liability
$149,000
Back
Back
Balance Sheet
Cellectar Biosciences, Inc. (CLRB)
Cellectar Biosciences, Inc. (CLRB)
source: myfinsight.com